Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma

被引：6

作者：

Sinakos, Emmanouil ^{[1
,2
]}

Dedes, Ioannis ^{[2
]}

Papalavrentios, Lavrentis ^{[1
,2
]}

Drevelegas, Antonios ^{[1
,2
]}

Akriviadis, Evangelos ^{[1
,2
]}

机构：

[1] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece

[2] Interbalkan Med Ctr, Thessaloniki, Greece

来源：

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 45卷 / 04期

关键词：

ANGIOGENESIS; MANAGEMENT; EFFICACY; TRIAL; TACE; HCC;

D O I：

10.3109/00365521003628335

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：511 / 512

页数：2

共 10 条

[1] Management of hepatoceullular carcinoma [J].

Bruix, J ;

Sherman, M .

HEPATOLOGY, 2005, 42 (05) :1208-1236

[2] Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].

Bruix, J ;

Sherman, M ;

Llovet, JM ;

Beaugrand, M ;

Lencioni, R ;

Burroughs, AK ;

Christensen, E ;

Pagliaro, L ;

Colombo, M ;

Rodés, J .

JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430

[3]

Erhardt A, 2009, HEPATOLOGY, V50, p865A

[4] Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinomas [J].

Jiang, Hongchi ;

Meng, Qinghui ;

Tan, Hongtao ;

Pan, Shangha ;

Sun, Bei ;

Xu, Ruian ;

Sun, Xueying .

INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (02) :416-424

[5] Sorafenib in advanced hepatocellular carcinoma [J].

Llovet, Josep M. ;

Ricci, Sergio ;

Mazzaferro, Vincenzo ;

Hilgard, Philip ;

Gane, Edward ;

Blanc, Jean-Frederic ;

Cosme de Oliveira, Andre ;

Santoro, Armando ;

Raoul, Jean-Luc ;

Forner, Alejandro ;

Schwartz, Myron ;

Porta, Camillo ;

Zeuzem, Stefan ;

Bolondi, Luigi ;

Greten, Tim F. ;

Galle, Peter R. ;

Seitz, Jean-Francois ;

Borbath, Ivan ;

Haussinger, Dieter ;

Giannaris, Tom ;

Shan, Minghua ;

Moscovici, Marius ;

Voliotis, Dimitris ;

Bruix, Jordi .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :378-390

[6] Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma [J].

Lo, CM ;

Ngan, H ;

Tso, WK ;

Liu, CL ;

Lam, CM ;

Poon, RTP ;

Fan, ST ;

Wong, J .

HEPATOLOGY, 2002, 35 (05) :1164-1171

[7]

Reyes DK, 2009, HEPATOLOGY, V50, p6A

[8] Angiogenesis and hepatocellular carcinoma [J].

Semela, D ;

Dufour, JF .

JOURNAL OF HEPATOLOGY, 2004, 41 (05) :864-880

[9] Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): The role of angiogenesis and invasiveness [J].

Sergio, Adriana ;

Cristofori, Chiara ;

Cardin, Romilda ;

Pivetta, Giorgio ;

Ragazzi, Roberto ;

Baldan, Anna ;

Girardi, Lisa ;

Cillo, Umberto ;

Burra, Patrizia ;

Giacomin, Anna ;

Farinati, Fabio .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (04) :914-921

[10] CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment [J].

Trotti, A ;

Colevas, AD ;

Setser, A ;

Rusch, V ;

Jaques, D ;

Budach, V ;

Langer, C ;

Murphy, B ;

Cumberlin, R ;

Coleman, CN ;

Rubin, P .

SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (03) :176-181

← 1 →